Influence of Menstrual Cycle Phases on the Glycemic Control of Aerobic or HIIT Exercise in Adult Women With Type 1 Diabetes
Launched by UNIVERSITY OF VALENCIA · Dec 6, 2024
Trial Information
Current as of August 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different phases of the menstrual cycle affect blood sugar levels during exercise in women with Type 1 diabetes. Researchers want to find out if aerobic exercises (like jogging or cycling) and high-intensity interval training (HIIT) have different impacts on blood sugar levels depending on where a woman is in her menstrual cycle. The goal is to create better exercise guidelines for women with diabetes and improve technologies like artificial pancreas systems, making them more effective for women.
To be eligible for the study, women aged 18 to 45 with Type 1 diabetes for more than two years and stable insulin use can participate. Participants should have good blood sugar control and engage in at least 90 minutes of physical activity each week, but they shouldn’t be competing in sports at an amateur or professional level. If you join the trial, you can expect to monitor how your blood sugar reacts to different exercises during your menstrual cycle, contributing valuable information that could help many women with diabetes manage their condition better.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age between 18-45 years T1D with a diabetes duration for more than 2 years Glycated hemoglobin (HbA1c) \< 8.5% (\<69 mmol mol-1) Stable insulin regimen in the past 6 months with less than 20% change in total insulin daily dose Multiple daily injections or insulin pump Weekly physical activity of 90 min or more, but no practicing any sport as amateur or professional.
- Exclusion Criteria:
- • Clinical conditions or use of medications (other than insulin) known to affect glycemic control (e.g., oral/parenteral steroids or metformin, among others).
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, Select One, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported